Skip to main content
. 2025 Sep 12;55:e266. doi: 10.1017/S0033291725101475

Table 1.

Participants’ characteristics

Placebo VPA
Sex (female/male) 23/3 20/2
Comorbid specific phobia (y/n) 11/15 8/14
DSM-IV diagnoses (animal type: spider) at follow-up (y/n) 19/7 14/8
Age (SD) 24.42 (4.44) 24.41 (4.33)
Body mass index (SD) 24.05 (3.88) 23.31 (3.18)